LINCOLN

Lincoln Pharmaceuticals Share PriceLincoln Pharmaceuticals

₹348.85
7.8 (2.29%)
As on 22 March, 2023 | 02:22 BSE: 531633 NSE: LINCOLN

Lincoln Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Lincoln Pharmaceuticals

Start SIP

Lincoln Pharmaceuticals Share Price

  • Over 1 Month -3.19%
  • Over 3 Month -2.62%
  • Over 6 Month 20.13%
  • Over 1 Year 3.1%

Lincoln Pharmaceuticals Key Statistics

P/E Ratio 9.8
PEG Ratio 4.1
Market Cap Cr 699
Price to Book Ratio 1.6
EPS 34.3
Dividend 0.4
Relative Strength Index 57.68
Money Flow Index 77.99
MACD Signal -0.5
Average True Range 13.27

Lincoln Pharmaceuticals Investment Rating

  • Master Rating:
  • Lincoln Pharmaceuticals has an operating revenue of Rs. 500.44 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 20% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 4% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lincoln Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 134141123103
Operating Expenses Qtr Cr 10711210785
Operating Profit Qtr Cr 27291717
Depreciation Qtr Cr 2222
Interest Qtr Cr 0001
Tax Qtr Cr 9866
Net Profit Qtr Cr 22241511

Lincoln Pharmaceuticals Technicals

EMA & SMA

Current Price
₹348.85
7.8 (2.29%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 335.06
  • 50 Day
  • 334.45
  • 100 Day
  • 329.86
  • 200 Day
  • 323.36
  • 20 Day
  • 336.92
  • 50 Day
  • 333.63
  • 100 Day
  • 333.07
  • 200 Day
  • 313.64

Lincoln Pharmaceuticals Resistance and Support

PIVOT
₹339.3
Resistance
First Resistance 350.35
Second Resistance 359.65
Third Resistance 370.7
RSI 57.68
MFI 77.99
MACD Single Line -0.5
MACD 0.41
Support
First Resistance 330
Second Resistance 318.95
Third Resistance 309.65

Lincoln Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 43,575 1,952,160 44.8
Week 59,316 2,786,073 46.97
1 Month 64,319 2,807,524 43.65
6 Month 62,554 3,476,116 55.57

Lincoln Pharmaceuticals Result Highlights

Lincoln Pharmaceuticals Synopsis

NSE-Medical-Diversified

Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 472.08 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2022. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.
Market Cap 698
Sales 500
Shares in Float 1.08
No of funds 10
Yield 0.44
Book Value 1.61
U/D Vol ratio 1.9
LTDebt / Equity
Alpha 0.01
Beta 0.81

Lincoln Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 46.34%44.08%44.08%
Mutual Funds
Foreign Portfolio Investors 1.44%0.63%0.64%
Individual Investors 36.61%39.13%39.12%
Others 15.61%16.16%16.16%

Lincoln Pharmaceuticals Management

Name Designation
Mr. Kishor M Shah Chairman
Mr. Mahendra G Patel Managing Director
Mr. Hashmukh I Patel Whole Time Director
Mr. Munjal M Patel Whole Time Director
Mr. Ashish R Patel Whole Time Director
Mr. Rajnikant G Patel Director
Mr. Ishwarlal A Patel Independent Director
Mr. Pirabhai R Suthar Independent Director
Mr. Meha M Patel Independent Director
Mr. Saurin J Parikh Independent Director

Lincoln Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lincoln Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Lincoln Pharmaceuticals FAQs

What is Share Price of Lincoln Pharmaceuticals ?

Lincoln Pharmaceuticals share price is ₹348 As on 22 March, 2023 | 02:08

What is the Market Cap of Lincoln Pharmaceuticals ?

The Market Cap of Lincoln Pharmaceuticals is ₹698.7 Cr As on 22 March, 2023 | 02:08

What is the P/E ratio of Lincoln Pharmaceuticals ?

The P/E ratio of Lincoln Pharmaceuticals is 9.8 As on 22 March, 2023 | 02:08

What is the PB ratio of Lincoln Pharmaceuticals ?

The PB ratio of Lincoln Pharmaceuticals is 1.6 As on 22 March, 2023 | 02:08

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number